ClinicalTrials.gg
RecruitingNCT07534215Updated Apr 21, 2026

The Effect of EEG and BIS-guided Anaesthesia on the Incidence of Emergent Delirium in Children

An interventional study of EEG monitoring and BIS monitoring in Emergence Delirium, Anesthesia, sponsored by University Hospital Ostrava. Recruiting at 1 site in Czechia. Open to participants aged 1 Year to 6 Years. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by University Hospital Ostrava · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2026, registered Apr 2026).
  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
1 Year to 6 Years
Sex
All
01

Study summary

The aim of the study is to compare two modalities of measuring the depth of general anaesthesia on the incidence of emergent delirium in children.

Read the detailed description

Preoperative preparation and the method of administering general anaesthesia will be conducted based on a standardised protocol. Each patient included in the study will be administered sedative premedication Midazolam at a dose of 0.5mg/kg per os 45-60 minutes before the operation. During transfer to the operating room, Parental Separation Anxiety Scale (PSAS) and Modified Yale Preoperative Anxiety Scale (m-YPAS) will be evaluated to assess the level of preoperative anxiety as a risk factor for emergent delirium (ED). Inhalation induction of general anaesthesia with a flow rate of 4l/min O2:air with Fio2 0.5 to achieve sufficient depth of general anaesthesia, followed by provision of peripheral venous catheter, administration of Sufentanil at a dose of 0.2uq/kg and Paracetamol 15mg/kg. Airways will be secured preferentially by a laryngeal mask, in case of leakage or the nature of the procedure by orotracheal intubation. After ensuring the airways, the gas flow is reduced to 2.5%. Immediately in the electroencephalography (EEG) group, a trained nurse connects the EEG and initiates monitoring with titration of Sevoflurane to achieve a sufficient depth of unconsciousness, which will be assessed by an EEG specialist.

In the Bispectral Index (BIS) group, the child will be equipped with a BIS electrode and the depth of general anaesthesia will be controlled with the aim of BIS values of 40-60.

The time from the start of the connection to the start of the measurement of the depth of anaesthesia, the total duration of the operation and anaesthesia will also be recorded.

During anaesthesia, in addition to vital functions, the concentration of the anaesthetic and its consumption, signs of insufficient depth of general anaesthesia will be recorded In the recovery room, scales to determine the presence of emergent delirium will be assessed - Paediatric Anesthesia Emergence Delirium scale (PAED) and Watcha scale, as well as Face, Legs, Activity, Cry, Consolability scale (FLACC) and other parameters.

02

Conditions studied

  • Emergence Delirium, Anesthesia

Browse trials for

Keywords

  • Emergence Delirium
  • EEG
  • Bispectral Index
  • General anaesthesia
03

In context

Emergence Delirium

751 studies on the registry are indexed under Emergence Delirium; 262 are open to participants now.

This study's planned enrollment of 540 is above the median of 120 across 464 interventional studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

University Hospital Ostrava is the lead sponsor of 148 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient aged 1-6 years indicated for surgery (hernioplasty, orchidopexy)
  • Consent of parents/legal guardians
  • Health status corresponding to ASA () I and II

Exclusion criteria

Exclusion Criteria:

  • Disagreement of parents/legal guardians with inclusion in the study
  • Neurological disease, severe hearing and vision impairment
  • Health status corresponding to ASA () III and above
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
540 participants (estimated)

Study arms

  • Experimental
    EEG monitoring

    Study subjects randomised into this arm will undergo EEG monitoring during anaesthesia.

    Diagnostic Test: EEG monitoring

  • Experimental
    BIS monitoring

    Study subjects randomised into this arm will undergo BIS monitoring during anaesthesia.

    Diagnostic Test: BIS monitoring

Interventions

  • Diagnostic testEEG monitoring

    EEG monitoring will be performed during anaesthesia.

  • Diagnostic testBIS monitoring

    BIS monitoring will be performed during anaesthesia.

06

What researchers measure

Primary outcomes

  1. Presence of ED (in EEG and BIS groups) - PAED scale

    The presence of emergence delirium in the EEG and BIS groups will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale at the recovery room. The Pediatric Anesthesia Emergence Delirium (PAED) Scale is a 5-item, validated observational tool used to measure the severity of delirium in children during anesthesia recovery, with scores \>10-12 indicating significant emergence delirium (ED).

    Time frame: 2 hours after surgery

  2. Presence of ED (in EEG and BIS groups) - Watcha scale

    The presence of emergence delirium in the EEG and BIS groups will be assessed using the Watcha scale at the recovery room. The Watcha scale is a simple 4-point observational tool used to assess pediatric emergence delirium (ED) (agitation or confusion) as children wake up from general anesthesia. It measures the severity of agitation, with scores \>2 generally indicating significant agitation or delirium.

    Time frame: 2 hours after surgery

  3. Presence of ED (in EEG and BIS groups) - FLACC scale

    The presence of emergence delirium in the EEG and BIS groups will be assessed using the FLACC scale at the recovery room. The FLACC scale (Face, Legs, Activity, Cry, Consolability) is a behavioral tool designed to measure pain in infants, young children (2 months to 7 years), and non-verbal patients. It evaluates five behaviors, scoring each from 0-2, for a total score of 0-10, where higher scores indicate greater pain.

    Time frame: 2 hours after surgery

Secondary outcomes

  1. Safety of EEG and BIS monitoring in relation to ED - heart rate

    The safety of EEG and BIS monitoring in relation to ED will be assessed using the monitoring of heart rate during anaesthesia and measured in beats per minute.

    Time frame: During general anaesthesia, up to 2 hours

  2. Safety of EEG and BIS monitoring in relation to ED - blood pressure

    The safety of EEG and BIS monitoring in relation to ED will be assessed using the monitoring of blood pressure during anaesthesia and measured in millimetres of mercury (mmHg).

    Time frame: During general anaesthesia, up to 2 hours

  3. Safety of EEG and BIS monitoring in relation to ED - patient movement

    The safety of EEG and BIS monitoring in relation to ED will be assessed using the monitoring of presence of patient movement during anaesthesia (Yes/No).

    Time frame: During general anaesthesia, up to 2 hours

  4. Safety of EEG and BIS monitoring in relation to ED - patient sweating

    The safety of EEG and BIS monitoring in relation to ED will be assessed using the monitoring of presence of patient sweating during anaesthesia (Yes/No).

    Time frame: During general anaesthesia, up to 2 hours

  5. Safety of EEG and BIS monitoring in relation to ED - patient lacrimation

    The safety of EEG and BIS monitoring in relation to ED will be assessed using the monitoring of presence of patient lacrimation during anaesthesia (Yes/No).

    Time frame: During general anaesthesia, up to 2 hours

07

Study locations

1 of 1 sites recruiting
  • University Hospital Ostrava
    Ostrava, Moravian-Silesian Region 708 52, Czechia
    Recruiting
    • Jiří Hynčica · Contactjiri.hyncica@fno.cz · +42059737
    • Vilém Novák, MD, Ph.D. · Principal investigator
    • Michal Frelich, MD, Ph.D. · Sub investigator
    • Eva Štěpánová, MD, Ph.D. · Sub investigator
    • Tereza Otipková, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data with other researchers. The data may be provided upon reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07534215
Responsible party
Sponsor
First posted
Apr 16, 2026
Start date
Jan 1, 2026
Primary completion
Oct 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Apr 21, 2026

Study contacts

Jiří Hynčica
Contact
jiri.hyncica@fno.cz
+42059737 ext. 2587
Vilém Novák, MD, Ph.D.
principal investigator · University Hospital Ostrava

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion